← Back to Search

Intervention for Family

N/A

Waitlist Available

Led By Wendy Duggleby, PhD

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 2 months, 4 months

Awards & highlights

Study Summary

This trial will test whether the MT4C-In Care toolkit can improve the quality of life, hope, social support, self-efficacy, and decrease the loss, grief and loneliness of family caregivers.

Eligible Conditions

Family
Dementia

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 2 months, 4 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 2 months, 4 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 months, 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from baseline in the 12-item Short-Form Health Survey (SF-12v2) - Mental Component Summary Score at two and four months

Secondary outcome measures

Change from baseline in 3 item loneliness score at 2 and 4 months.

Change from baseline in Multidimensional Scale of Perceived Social Support at 2 and 4 months.

Change from baseline in the 12-item Short-Form Health Survey (SF-12v2) - Physical Component Summary Score at 2 and 4 months.

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

The intervention group will receive access to My Tools for Care - In Care for 2 months. They will also receive a copy of the Alzheimer Society's "The Progression Of Alzheimer's Disease - Overview Booklet".

Group II: ControlActive Control1 Intervention

The control group will not receive the intervention (i.e. they will not access My Tools for Care - In Care). They will receive a copy of the Alzheimer Society's "The Progression Of Alzheimer's Disease - Overview Booklet". Data collection for outcome variables will be the same as participants in the intervention group.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

My Tools for Care - In Care

2020

N/A

~240

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor

888 Previous Clinical Trials

384,724 Total Patients Enrolled

2 Trials studying Family

236 Patients Enrolled for Family

Public Health Agency of Canada (PHAC)OTHER_GOV

45 Previous Clinical Trials

96,899 Total Patients Enrolled

Wendy Duggleby, PhDPrincipal InvestigatorUniversity of Alberta

2 Previous Clinical Trials

218 Total Patients Enrolled

1 Trials studying Family

199 Patients Enrolled for Family

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently being accepted for enrollment in this research?

"This particular clinical trial, which was posted February 3rd 2020 and last edited on September 28th 2022 is not presently accepting patients. However, 406 other medical studies are actively looking for volunteers as of now."

Answered by AI

How much availability is there of this research study within Canada?

"Currently, participants are being recruited at 4 medical sites located in Hamilton, Saskatoon, Winnipeg and other nearby cities. Prospective patients should consider the closest location to minimize travel expenses if they choose to participate."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Supporting Family Caregivers of Persons Living With Dementia: Effectiveness and Sustainability of MT4C-In Care

2020. "Supporting Family Caregivers of Persons Living With Dementia: Effectiveness and Sustainability of MT4C-In Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04226872.